Overview
The melanocortin receptor family comprises five G protein-coupled receptors (MC1R through MC5R) that respond to endogenous peptide ligands derived from the proopiomelanocortin (POMC) precursor protein. These receptors are distributed across multiple tissue types and are involved in a diverse range of biological signalling functions. They represent an important research target for synthetic peptide compounds due to their broad physiological relevance and well-characterised pharmacology.
The Five Melanocortin Receptors
MC1R (Melanocortin 1 Receptor)
Primarily expressed in melanocytes (skin pigmentation cells). MC1R activation controls the switch between eumelanin (dark pigment) and phaeomelanin (red/yellow pigment) production. Also expressed in immune cells and has been investigated in research examining inflammatory pathway signalling.
MC2R (Melanocortin 2 Receptor)
The ACTH receptor — highly selective for adrenocorticotropic hormone (ACTH). Expressed primarily in the adrenal cortex, where it mediates cortisol production in response to ACTH stimulation. MC2R is unique among the melanocortin receptors in its high selectivity for a single endogenous ligand.
MC3R (Melanocortin 3 Receptor)
Expressed in the hypothalamus, limbic system, and peripheral tissues. MC3R has been investigated in preclinical research examining energy homeostasis signalling, feeding behaviour pathway regulation, and cardiovascular function.
MC4R (Melanocortin 4 Receptor)
Expressed predominantly in the central nervous system, particularly the hypothalamus. MC4R is one of the most extensively studied melanocortin receptors, with a large published literature examining its role in energy balance signalling, metabolic pathway regulation, and autonomic nervous system function.
MC5R (Melanocortin 5 Receptor)
Widely expressed in peripheral tissues including exocrine glands. MC5R has been investigated in research examining exocrine gland secretory function and immune pathway interactions.
Endogenous Ligands
The principal endogenous ligands for melanocortin receptors are derived from proteolytic processing of the POMC precursor:
α-MSH (alpha-melanocyte stimulating hormone): Binds MC1R, MC3R, MC4R, and MC5R; does not bind MC2R
β-MSH: Binds MC3R and MC4R
γ-MSH: Binds MC3R
ACTH: Binds all five receptors; selective endogenous agonist for MC2R
Synthetic Melanocortin Receptor Ligands in Research
Several synthetic peptide compounds have been developed as research tools for studying melanocortin receptor biology:
PT-141 (Bremelanotide): A cyclic heptapeptide analog of α-MSH with non-selective binding across MC1R, MC3R, MC4R, and MC5R. Used as a reference compound in preclinical research examining central melanocortin system signalling and neuromodulatory pathway interactions.
Melanotan II: A cyclic analog of α-MSH with enhanced receptor binding affinity relative to the native sequence. Used in receptor binding affinity and selectivity assay panels.
Research Applications
Synthetic melanocortin receptor ligands are applied as reference compounds in receptor binding assays, selectivity panels, and preclinical signalling pathway research. Their well-characterised pharmacological profiles make them useful tools for investigating the downstream consequences of melanocortin receptor activation across the MC receptor family.
